Publications by authors named "Ciro Maria Improta"

Claim this Profile
B
Brentuximab vedotin plus nivolumab as bridging therapy to CAR T-cells in relapsed/refractory primary mediastinal B-cell lymphoma.
Armando Santoro, Ciro Maria Improta, Barbara Sarina, Daniele Mannina, Chiara De Philippis

Haematologicaยท September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis